Dalbavancin Use in Bone and Joint Infections

Dalbavancin Use in Bone and Joint Infections

Background: Dalbavancin (DAL) off-label use for treating bone and joint infections has increased especially as long-term intravenous access is not needed. Little is known about the effectiveness and safety of its use. Methods: This retrospective, single-center, descriptive study included adults trea...

Full description

Saved in:
Bibliographic Details
Main Authors: Liam P. Alderson, BS, Srivani Sanikommu, MD, Simon C. Mears, MD, PhD, C. Lowry Barnes, MD, Benjamin M. Stronach, MD, Jeffrey B. Stambough, MD, Jennifer McDonald, RPh, Traci Motes, APRN, Brett Bailey, PharmD, Ryan K. Dare, MD
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Arthroplasty Today
Subjects:
Dalbavancin (DAL)
Peri-prosthetic joint infection (PJI)
Osteomyelitis
Methicillin-resistant Staphylococcus aureus (MRSA)
Online Access:http://www.sciencedirect.com/science/article/pii/S2352344124001900
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2352344124001900

Similar Items